Pınar, İbrahim Ethem, and Vildan Ozkocaman. 2023. “Efficacy and Safety Outcomes of Single-Agent Ibrutinib Therapy in Chronic Lymphocytic Leukemia and Relapsed Refractory Mantle-Cell Lymphoma”. The European Research Journal 9 (6): 1483-92. https://doi.org/10.18621/eurj.1359362.